Sattva S. Neelapu - Publications, H-index & Citations

Sattva S. Neelapu

Department of Lymphoma and Myeloma

83H指数

869论文数

4.2W被引数

收录论文 175

发表时间

Enabling access to talicabtagene autoleucel in relapsed/refractory B-cell malignancies; multicenter real-world evidence on delivery, efficacy and safety 为复发/难治性B细胞恶性疾病启用talicabtagene autoleucel的获取途径；关于其配送、有效性和安全性的多中心真实世界证据

Blood Cancer Journal

IF11.6

2026-07-16

OAAI

Atharva Karulkar; Hasmukh Jain; Neeraj Sidharthan; Dinesh Bhurani; Sameer Melinkeri; Pavan Kumar Boyella; Prashant Mehta; Esha Kaul; Sanket Shah; Jayachandran P. K.; Chandran Nair; Rahul Bhargava; Bhausaheb Bagal; Lingaraj Nayak; Alok Shetty; Hari Menon; Rakesh Reddy Boya; Ram Abhinav; Devanshi Kalra; Smrithi Ravikumar; Jayashree Thorat; Shalini Purwar; Nirali N. Shah; Terry Fry; Nitin Jain; Sattva Neelapu; Manju Sengar; Rahul Purwar

Long-term clinical outcomes from the smart start trial: rituximab, lenalidomide and ibrutinib in patients with newly diagnosed large B-cell lymphoma SMART START试验的长期临床结果：利妥昔单抗、来那度胺和伊布替尼在 newly diagnosed large B-cell lymphoma 患者中的应用

Blood Cancer Journal

IF11.6

2026-07-02

OAAI

Karan L. Chohan; Eduardo Edelman Saul; R. Eric Davis; Fredrick Hagemeister; Raphael Steiner; Luis Fayad; Sairah Ahmed; Alma Rodriguez; Swaminathan P. Iyer; Ranjit Nair; Francisco Vega; Dai Chihara; Paolo Strati; Preetesh Jain; Luis Malpica Castillo; Chijioke Nze; Fateeha Furqan; Ayushi Chauhan; Mark P. Hamilton; Jared Henderson; Anath C. Lionel; Christopher R. Flowers; Sattva Neelapu; Michael R. Green; Jason Westin

Recommendations for Defining Chimeric Antigen Receptor T-Cell (CAR T) Dose-Limiting Toxicities (DLTs) for Future Early-Phase CAR T Therapy Studies 关于未来早期CAR T疗法研究中定义嵌合抗原受体T细胞（CAR T）剂量限制性毒性（DLTs）的建议

Transplantation and Cellular Therapy

IF4.4

2025-11-07

PREAI

Frederick L. Locke; Sarah Nikiforow; Matthew J. Frigault; David G. Maloney; Marco Davila; David B. Miklos; Yi Lin; Judy Vong; Nirav N. Shah; Sattva S. Neelapu; John Welch; Eric Ng; Caron Jacobson; Marcela V. Maus

Erratum to <[Transplant Cell Ther. 2023 Jul;29(7):438.e1-438.e16. Epub 2023 Mar 9]>勘误：《免疫效应细胞相关噬血细胞性淋巴组织细胞增多症样综合征》\[Transplant Cell Ther. 2023 Jul;29(7):438.e1-438.e16. Epub 2023 Mar 9\]

Transplantation and Cellular Therapy

IF4.4

2025-10-30

OAAI

Melissa R. Hines; Tristan E. Knight; Kevin O. McNerney; Mark B. Leick; Tania Jain; Sairah Ahmed; Matthew J. Frigault; Joshua A. Hill; Michael D. Jain; William T. Johnson; Yi Lin; Kris M. Mahadeo; Gabriela M. Maron; Rebecca A. Marsh; Sattva S. Neelapu; Sarah Nikiforow; Amanda K. Ombrello; Nirav N. Shah; Aimee C. Talleur; David Turicek; Anant Vatsayan; Sandy W. Wong; Marcela V. Maus; Krishna V. Komanduri; Nancy Berliner; Jan-Inge Henter; Miguel-Angel Perales; Noelle V. Frey; David T. Teachey; Matthew J. Frank; Nirali N. Shah

Frontline acalabrutinib, lenalidomide and rituximab for advanced stage follicular lymphoma with high tumor burden: phase II trial 一线阿卡巴鲁替尼、来那度胺和利妥昔单抗治疗高肿瘤负荷的晚期滤泡性淋巴瘤：II期试验

Nature Communications

IF15.7

2025-08-07

OAAI

Paolo Strati; Lei Feng; Jason R. Westin; Ranjit Nair; Luis E. Fayad; Maria A. Rodriguez; Dai Chihara; Luis Malpica; Jared Henderson; Mariana Gallardo; Marissa Rivera; Iris Wang; Anastasiia Bolshakova; Anastasia Radko; David Kurtz; Stefan K. Alig; Christopher R. Flowers; Ash A. Alizadeh; Sattva S. Neelapu

A phase 2 study of obinutuzumab combined with lenalidomide in previously untreated high tumor burden follicular lymphoma 一项奥滨尤妥珠单抗联合来那度胺治疗既往未治的高肿瘤负荷滤泡性淋巴瘤的II期研究

Blood Advances

IF7.1

2025-06-17

OAAI

Neha Akkad; Lei Feng; Jason R. Westin; Fredrick B. Hagemeister; Hun Ju Lee; Luis Fayad; Sairah Ahmed; Ranjit Nair; Maria Alma Rodriguez; Paolo Strati; Dai Chihara; Christopher R. Flowers; Linda Claret; Karina Ibanez; Michael Wang; Nathan H. Fowler; Jared Henderson; R. Eric Davis; Sattva S. Neelapu; Michael Green; Loretta J. Nastoupil

Incidence and Risk Factors for Pneumonitis Associated With Checkpoint Inhibitors in Relapsed or Refractory Lymphoma 与检查点抑制剂相关的肺炎在复发或难治性淋巴瘤中的发生率和危险因素

clinical lymphoma myeloma leukemia

IF0

2025-05-16

PREAI

Felipe Soto; Ugochi Ebinama; William P. Brasher; William C. Harding; Alberto Goizueta; Jeremy R. Walder; Alexandra Ewing; Vickie R. Shannon; Saadia A. Faiz; Mehmet Altan; Girish Shroff; Lei Feng; Sattva Neelapu; Sairah Ahmed; Loretta J Nastoupil; Ajay Sheshadri

Phase I study of pomalidomide in relapsed or refractory Waldenström macroglobulinaemia 泊马利度胺治疗复发或难治性华氏巨球蛋白血症的I期研究

BRITISH JOURNAL OF HAEMATOLOGY

IF3.8

2025-05-13

OAAI

Karan L. Chohan; Donna M. Weber; Lei Feng; L. Michael Wang; Sattva S. Neelapu; Jasper Olsem; Ralph J. Johnson; Claudia Morales de Partovi

Nivolumab plus relatlimab for patients with relapsed or progressed B-cell malignancies in RELATIVITY-022 纳武利尤单抗联合罗特利珠单抗治疗复发或进展性B细胞恶性肿瘤的RELATIVITY-022研究

Blood Advances

IF7.1

2025-03-05

OAAI

Ajay K. Gopal; Philippe Armand; Sattva S. Neelapu; Nancy L. Bartlett; Stephen E. Spurgeon; John Kuruvilla; Kerry J. Savage; John P. Leonard; Arnold B. Gelb; Nasir Ahmed; Shiqi Dong; Sai Praneeth Bathena; Rasika Suryawanshi; Jenny Qun Wu; Sheen Wang; Douglas E. Gladstone

Characterization of Lymphopenia and Correlating the Risk of Cytopenias With Dose and Bone Marrow Volume Irradiated in Aggressive B Cell Lymphoma Patients Bridged With Radiation Therapy for Chimeric Antigen Receptor-T Cell Therapy

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

IF6.5

2025-03-01

PREAI

Manzar, Gohar S.; Wu, Susan Y.; Dudzinski, Stephanie O.; Cha, Elaine E.; Yoder, Alison K.; Corrigan, Kelsey L.; Nasr, Lewis F.; Sallard, Gabrielle; Ahmed, Sairah; Fayad, Luis E.; Chihara, Dai; Nair, Ranjit; Westin, Jason R.; Daher, May; Neelapu, Sattva S.; Nastoupil, Loretta J.; Gunther, Jillian R.; Pinnix, Chelsea C.; Dabaja, Bouthaina S.; Strati, Paolo; Fang, Penny Q.

Outcomes with bridging radiation therapy prior to chimeric antigen receptor T-cell therapy in patients with aggressive large B-cell lymphomas

FRONTIERS IN IMMUNOLOGY

IF5.9

2025-01-31

OAAI

Manzar, Gohar S.; Pinnix, Chelsea C.; Dudzinski, Stephanie O.; Marqueen, Kathryn E.; Cha, Elaine E.; Nasr, Lewis F.; Yoder, Alison K.; Rooney, Michael K.; Strati, Paolo; Ahmed, Sairah; Nze, Chijioke; Nair, Ranjit; Fayad, Luis E.; Wang, Michael; Nastoupil, Loretta J.; Westin, Jason R.; Flowers, Christopher R.; Neelapu, Sattva S.; Gunther, Jillian R.; Dabaja, Bouthaina S.; Wu, Susan Y.; Fang, Penny Q.

Role of Pulmonary Function Tests to Predict Complications After Chimeric Antigen Receptor T-Cell Therapy 肺功能测试在预测嵌合抗原受体T细胞疗法后并发症中的作用

clinical lymphoma myeloma leukemia

IF0

2025-01-28

PREAI

Jeremy Walder; Felipe Soto-Lanza; Lei Feng; Sairah Ahmed; Sattva Neelapu; Amy Ayers; Horiana B. Grosu; Saadia A. Faiz; Loretta Nastoupil; Ajay Sheshadri

Imaging Activated Innate Immune Myeloid Cells in Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) Following CAR T-Cell Therapy CAR T细胞疗法后免疫效应细胞相关神经毒性综合征（ICANS）中成像活化的先天免疫髓系细胞

BLOOD

IF23.1

2024-11-05

PREAI

Al Zaki, Ajlan; Sutton, Margie; Rehman, Abdur; Le, Cao Cuong; Gammon, Seth; Napoli, Arianna; Yang, Ping; Saini, Neeraj Y.; Ahmed, Sairah; Issa, Ghayas C.; Kebriaei, Partow; Davies, Michael; Shpall, Elizabeth J.; Varghese, Jeena; Flynt, Lesley; Neelapu, Sattva S.; Piwnica-Worms, David

Clinical Response after Allogeneic CAR T Cell Therapy Is Linked to Expansion of Identical CD8+Effector-like T Cell Clones 同种异体CAR T细胞疗法后的临床反应与相同CD8+效应样T细胞克隆的扩增相关

BLOOD

IF23.1

2024-11-05

PREAI

Jallouk, Andrew P.; Ge, Zhongqi; Kaimal, Vivek; Robbins, Paul B.; Roberts, Zachary J.; Neelapu, Sattva S.; Bachireddy, Pavan

Personalized Neoantigen Peptide Vaccine with or without Lenalidomide for Patients with Intermediate or High Risk Smoldering Multiple Myeloma (SMM) to Prevent Progression to Multiple Myeloma (MM)个性化新抗原肽疫苗联合或不联合来那度胺用于中危或高危冒烟型多发性骨髓瘤(SMM)患者，以预防进展为多发性骨髓瘤(MM)

BLOOD

IF23.1

2024-11-05

PREAI

Patel, Krina K.; Manasanch, Elisabet E.; Lee, Hans C.; Ye, J. Christine; Thomas, Sheeba K.; Weber, Donna M.; Becnel, Melody R.; Gaballa, Mahmoud R.; Bansal, Hima; Berkova, Zuzana; Neelapu, Sattva S.; Haymaker, Cara L.; Dang, Minghao; Wang, Linghua; Lizee, Greg; Orlowski, Robert Z.

Radiation Therapy and Monocyte Activation in Large B-Cell Lymphoma Patients Treated with CAR T-Cell Therapy 放射治疗与接受CAR T细胞疗法的大B细胞淋巴瘤患者的单核细胞激活

BLOOD

IF23.1

2024-11-05

PREAI

Fang, Penny Q.; Wu, Susan Y.; Gunther, Jillian R.; Frank, Alena; Zemskiy, Pavel; Zaitsev, Aleksandr; Bolshakov, Evgenii S.; Terenteva, Anastasiya; Nomie, Krystle; Abreu, Michelly; Ow, Karla; Santiago, Minifrida; Uarghese, Jaimole; Ayers, Amy; Henderson, Jared; Ahmed, Sairah; Westin, Jason R.; Flowers, Christopher R.; Neelapu, Sattva S.; Dabaja, Bouthaina S.; Pinnix, Chelsea C.; Strati, Paolo

Impact of Inflammation, Tumor and Product Attributes on Clinical Outcomes in Patients with Relapsed/Refractory Follicular Treated with Ciloleucel 炎症、肿瘤和产品属性对接受Ciloleucel治疗的复发/难治性滤泡性淋巴瘤患者临床结局的影响

BLOOD

IF23.1

2024-11-05

PREAI

Poddar, Soumya; Yan, Jiali; Tiwari, Gayatri; Rinchai, Darawan; Zhang, Wangshu; Budka, Justin; Peng, Weixin; Salunkhe, Shruti; Davis, Madison; Song, Qinghua; Beygi, Sara; Miao, Harry; Mattie, Mike; Shen, Rhine; Jacobson, Caron A.; Bedognetti, Davide; Filosto, Simone; Neelapu, Sattva S.

Tocilizumab Prophylaxis Following Axicabtagene Ciloleucel in Relapsed or Refractory Large B-Cell Lymphoma

TRANSPLANTATION AND CELLULAR THERAPY

IF4.4

2024-11-01

OAAI

Locke, Frederick L.; Neelapu, Sattva S.; Bartlett, Nancy L.; Lekakis, Lazaros J.; Jacobson, Caron A.; Braunschweig, Ira; Oluwole, Olalekan O.; Siddiqi, Tanya; Lin, Yi; Timmerman, John M.; Kersten, Marie Jose; Zheng, Yan; Zhang, Teresa; Nater, Jenny; Shen, Rhine; Miao, Harry; Kim, Jenny J.; Miklos, David B.

Outcomes and toxicities in patients with diffuse-large B cell lymphoma involving the gastrointestinal tract and digestive organs

FRONTIERS IN ONCOLOGY

IF3.3

2024-09-11

OAAI

Manzar, Gohar S.; Cha, Elaine E.; Corrigan, Kelsey L.; Yoder, Alison K.; Schrank, Benjamin R.; Nasr, Lewis F.; Chihara, Dai; Castillo, Luis Malpica; Nair, Ranjit; Jain, Preetesh; Neelapu, Sattva S.; Rodriguez, Maria A.; Strati, Paolo; Nastoupil, Loretta J.; Gunther, Jillian R.; Dabaja, Bouthaina S.; Pinnix, Chelsea C.; Wu, Susan Y.; Fang, Penny Q.

Personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma: a non-randomized phase 1 trial

NATURE COMMUNICATIONS

IF15.7

2024-08-11

OAAI

Szymura, Szymon J.; Wang, Lin; Zhang, Tiantian; Cha, Soung-chul; Song, Joo; Dong, Zhenyuan; Anderson, Aaron; Oh, Elizabeth; Lee, Vincent; Wang, Zhe; Parshottam, Sapna; Rao, Sheetal; Olsem, Jasper B.; Crumpton, Brandon N.; Lee, Hans C.; Manasanch, Elisabet E.; Neelapu, Sattva; Kwak, Larry W.; Thomas, Sheeba K.

研究方向